Teicoplanin
Teicoplanin is an unknown pharmaceutical. It is currently being investigated in clinical studies.
Download report
Favorite
Commercial
Therapeutic Areas
No data
Trade Name
FDA
EMA
No data
Drug Products
FDA
EMA
New Drug Application (NDA)
New Drug Application (NDA)
Abbreviated New Drug Application (ANDA)
Abbreviated New Drug Application (ANDA)
No data
Labels
FDA
EMA
No data
Indications
FDA
EMA
No data
Agency Specific
FDA
EMA
No data
Patent Expiration
No data
HCPCS
No data
Clinical
Clinical Trials
21 clinical trials
View more details
Mock data
Subscribe for the real data
Subscribe for the real data
Indications Phases 4
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Febrile neutropenia | D064147 | — | — | — | 1 | 1 | 2 | ||
| Infections | D007239 | EFO_0000544 | — | — | — | 1 | 1 | 2 | |
| Wound infection | D014946 | — | — | — | 1 | — | 1 | ||
| Bacteremia | D016470 | EFO_0003033 | R78.81 | — | — | — | 1 | — | 1 |
| Catheter-related infections | D055499 | — | — | — | 1 | — | 1 | ||
| Biliary liver cirrhosis | D008105 | K74.3 | — | — | — | 1 | — | 1 | |
| Patient compliance | D010349 | — | — | — | 1 | — | 1 | ||
| Colitis | D003092 | EFO_0003872 | K52.9 | — | — | — | 1 | — | 1 |
| Staphylococcal infections | D013203 | A49.01 | — | — | — | 1 | — | 1 |
Indications Phases 3
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Infectious skin diseases | D012874 | — | — | 1 | — | — | 1 | ||
| Soft tissue infections | D018461 | — | — | 1 | — | — | 1 | ||
| Scoliosis | D012600 | EFO_0004273 | M41 | — | — | 1 | — | — | 1 |
| Intervertebral disc displacement | D007405 | EFO_1001800 | — | — | 1 | — | — | 1 |
Indications Phases 2
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Osteomyelitis | D010019 | EFO_0003102 | M86 | — | 1 | — | — | — | 1 |
Indications Phases 1
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Cystic fibrosis | D003550 | EFO_0000390 | E84 | 1 | — | — | — | — | 1 |
Epidemiology
Epidemiological information for investigational and approved indications
View more details
Drug
General
| Drug common name | TEICOPLANIN |
| INN | teicoplanin |
| Description | Teicoplanin is an antibiotic used in the prophylaxis and treatment of serious infections caused by Gram-positive bacteria, including methicillin-resistant Staphylococcus aureus and Enterococcus faecalis. It is a semisynthetic glycopeptide antibiotic with a spectrum of activity similar to vancomycin. Its mechanism of action is to inhibit bacterial cell wall synthesis.
|
| Classification | Unknown |
| Drug class | antibacterials (Actinoplanes strains) |
| Image (chem structure or protein) |  |
| Structure (InChI/SMILES or Protein Sequence) | — |
Target
Agency Approved
No data
Alternate
No data
Variants
Clinical Variant
No data
Financial
No data
Trends
PubMed Central
Top Terms for Disease or Syndrome:
Mock data
Subscribe for the real data
Subscribe for the real data
Additional graphs summarizing 10,639 documents
View more details
Safety
Black-box Warning
No Black-box warning
Adverse Events
Top Adverse Reactions
Mock data
Subscribe for the real data
Subscribe for the real data
1,839 adverse events reported
View more details
Premium feature
Learn more about premium features at pharmakb.com
Learn more